Emma Walmsley, CEO of GSK Pharmaceuticals, shared a post on LinkedIn:

“Today I’m delighted to share another quarter of excellent performance for GSK with lots to be proud of. We’re preventing and changing the course of disease for millions of people and we expect this strong momentum to continue – delivering another year of meaningful growth in sales and earnings. This is exactly what getting ahead of disease together looks like.

Media and investors can watch this short clip for more.”

Source: Emma Walmsley/LinkedIn